267 related articles for article (PubMed ID: 32346613)
21. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
22. Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
Yu J; Xie M; Ge S; Chai P; Zhou Y; Ruan J
Front Oncol; 2020; 10():580029. PubMed ID: 33330057
[TBL] [Abstract][Full Text] [Related]
23. Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma.
Gong Z; Jia Q; Chen J; Diao X; Gao J; Wang X; Zhu B
J Thorac Oncol; 2019 May; 14(5):857-866. PubMed ID: 30768970
[TBL] [Abstract][Full Text] [Related]
24. Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
Lv Z; Lei T
BMC Cancer; 2020 Jan; 20(1):56. PubMed ID: 31987030
[TBL] [Abstract][Full Text] [Related]
25. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
[TBL] [Abstract][Full Text] [Related]
26. Immunogenomic Profiling and Classification of Prostate Cancer Based on HIF-1 Signaling Pathway.
Song J; Chen W; Zhu G; Wang W; Sun F; Zhu J
Front Oncol; 2020; 10():1374. PubMed ID: 32850440
[TBL] [Abstract][Full Text] [Related]
27. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma.
Li C; Tian C; Liu Y; Liang J; Zeng Y; Yang Q; Liu Y; Wu D; Wu J; Wang J; Zhang K; Gu F; Hu Y; Liu L
Front Genet; 2021; 12():619821. PubMed ID: 34122500
[TBL] [Abstract][Full Text] [Related]
29. Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma.
Ge X; Liu Z; Weng S; Xu H; Zhang Y; Liu L; Dang Q; Guo C; Beatson R; Deng J; Han X
Comput Struct Biotechnol J; 2022; 20():3449-3460. PubMed ID: 35832634
[TBL] [Abstract][Full Text] [Related]
30. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies.
Xue L; Bi G; Zhan C; Zhang Y; Yuan Y; Fan H
Front Oncol; 2020; 10():835. PubMed ID: 32537435
[No Abstract] [Full Text] [Related]
32. Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma.
Wang X; Li Y; Hu H; Zhou F; Chen J; Zhang D
Genet Mol Biol; 2020 Jun; 43(3):e20190164. PubMed ID: 32484849
[TBL] [Abstract][Full Text] [Related]
33. Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
Wei Y; Ou T; Lu Y; Wu G; Long Y; Pan X; Yao D
PeerJ; 2020; 8():e10414. PubMed ID: 33282564
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes.
Isaeva OI; Sharonov GV; Serebrovskaya EO; Turchaninova MA; Zaretsky AR; Shugay M; Chudakov DM
J Immunother Cancer; 2019 Oct; 7(1):279. PubMed ID: 31665076
[TBL] [Abstract][Full Text] [Related]
35. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X
J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680
[TBL] [Abstract][Full Text] [Related]
36. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
37. An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma.
Givechian KB; Garner C; Benz S; Song B; Rabizadeh S; Soon-Shiong P
Oncotarget; 2019 Mar; 10(19):1840-1849. PubMed ID: 30956762
[TBL] [Abstract][Full Text] [Related]
38. Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape.
Huang L; Liu X; Li L; Wang L; Wu N; Liu Z
Med Oncol; 2022 May; 39(5):92. PubMed ID: 35568771
[TBL] [Abstract][Full Text] [Related]
39.
Yu J; Hou M; Pei T
DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
[TBL] [Abstract][Full Text] [Related]
40. Classification of gastric cancers based on immunogenomic profiling.
Liu Z; Jiang Z; Wu N; Zhou G; Wang X
Transl Oncol; 2021 Jan; 14(1):100888. PubMed ID: 33096337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
